Cargando…
The Multi-Purpose Tool of Tumor Immunotherapy: Gene-Engineered T Cells
A detailed summary of the published clinical trials of chimeric antigen receptor T cells (CAR-T) and TCR-transduced T cells (TCR-T) was constructed to understand the development trend of adoptive T cell therapy (ACT). In contrast to TCR-T, the number of CAR-T clinical trials has increased dramatical...
Autores principales: | Mo, Zeming, Du, Peixin, Wang, Guoping, Wang, Yongsheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5535725/ https://www.ncbi.nlm.nih.gov/pubmed/28775789 http://dx.doi.org/10.7150/jca.18681 |
Ejemplares similares
-
CEACAM1 as a multi-purpose target for cancer immunotherapy
por: Dankner, Matthew, et al.
Publicado: (2017) -
Advances in Engineering Cells for Cancer Immunotherapy
por: Xu, Xiao, et al.
Publicado: (2019) -
TCR engineered T cells for solid tumor immunotherapy
por: Zhang, Yikai, et al.
Publicado: (2022) -
Purposeful engineering economics
por: Chadderton, Ronald A
Publicado: (2015) -
Engineering approaches for studying immune-tumor cell interactions and immunotherapy
por: Shelton, Sarah E., et al.
Publicado: (2020)